SUMMARY
Since its debut in 2002, the SBN’s Biotech Expo and Conference has established itself as the leading event showcasing the best and the brightest of the BC Biotech and Life Sciences industry. This annual event continues to attract and unite 100+ students every year, along with professionals from the life sciences, pharmaceutical and clinical sectors among many others. We’ve also had the pleasure of hosting several prominent organizations as exhibitors and encourage public debate via thought-provoking presentations. The result is a gathering of students and professionals, eager to share ideas and forge a strong biotech community that will help shape BC’s biotech future.
Why attend the Biotech Expo and Conference?
Hear from and meet with the movers and shakers of some of the hottest areas in the global and local biotech sphere. If you are interested in learning about potential career paths in life sciences and biotech or need to build your network of like-minded peers and industry professionals, then you should Join us at our Annual Biotech Expo and Conference on February 22 for this exclusive opportunity.
The evening will include:
- Formal networking with students from different backgrounds and industry mentors over drinks and catered appetizers.
- A high-level keynote speaker, sharing her personal career journey.
- Two to three breakout sessions exploring exciting career paths.
- A chance to visit with exhibitors and leaders in BC’s life science and biotech industry.
AGENDA:
| Time | Session | |
5:30-6:45pm |
Registration, Networking Reception and Booth Exhibits |
|
7:00-7:30pm |
KeynoteJennifer Gardy, Molecular EpidemiologistBC Centre for Disease Control |
|
7:45-8:00pm |
Breakout Session 1Jennifer Kaufman-Shaw, Vice President
|
|
8:10-8:25pm |
Breakout Session 2Helen Burt, Associate Vice President
|
|
8:35-8:50pm |
Breakout Session 3Nicole Quinn, ManagerScientific Communication and Publishing
|
SPEAKER INFORMATION:
Keynote Speaker
Jennifer Gardy
Molecular Epidemiologist, BC Centre for Disease Control
Dr. Gardy is a Senior Scientist at the British Columbia Centre for Disease Control, responsible for the genomics/molecular epidemiology portfolio in Communicable Disease Prevention and Control Services. An Assistant Professor in School of Population and Public Health (SPPH) since March, 2013, Dr. Gardy is also an Associate Member of UBC’s Department of Microbiology and Immunology in the Faculty of Science, and she holds a Tier 2 Canada Research Chair in Public Health Genomics. She obtained her BSc in Cell Biology & Genetics from UBC in 2000 and completed her PhD at Simon Fraser University in 2006 under Dr. Fiona Brinkman, working on bacterial genomics and bioinformatics-based predictive methods. She completed three years of postdoctoral training in the R.E.W. Hancock laboratory at UBC, using systems biology techniques to study the mammalian innate immune response and working on visualization tools to facilitate scientists’ exploration of biological network data. Dr. Gardy joined BCCDC in 2009, where she works in the emerging field of genomic epidemiology, combining whole genome sequencing with both new and old epidemiological techniques, including information visualization, to understand the origins, evolution, and transmission dynamics of outbreak organisms, including tuberculosis.
Session Speakers
Jennifer Kaufman-Shaw
Vice-President, Intellectual Property and Legal Affairs, Zymeworks Inc.
Dr. Jennifer Kaufman-Shaw has been Vice President of Intellectual Property & Legal Affairs at Zymeworks Inc. since August 2014. Dr. Kaufman-Shaw served as Vice President of Intellectual Property at Sirius Genomics Inc. She has over 20 years of scientific legal expertise. She served as Vice President of Patent Counsel at QLT Inc. Prior to joining Zymeworks, she was a Co-Founder of ImStar Therapeutics Inc. and also served as its Vice President, Intellectual Property and Legal Affairs. Dr. Kaufman-Shaw has had the role of intellectual property counsel for numerous licensing, acquisition and joint development transactions and has conducted patent due diligence on over 100 medically-related products and technologies. Prior to becoming in-house counsel, Dr. Kaufman-Shaw served as a lawyer in the Technology Group of an established law firm. She serves as Director of MRM Proteomics Inc. She clerked for the Alberta Court of Queen’s Bench and Court of Appeal, articled to the late Honourable Justice J.W. McClung, before being called to the Alberta Bar. She is a registered patent agent and a registered trade mark agent. Dr. Kaufman-Shaw obtained both her PhD in biochemistry and her LLB from the University of Alberta.
Helen Burt
Associate Vice-President, Research and Innovation, UBC
Dr. Helen M. Burt is the Associate Vice-President Research & Innovation at the University of British Columbia. From 2016-2017, she served as the Vice-President Research pro tem. Burt is a professor of drug delivery in the UBC Faculty of Pharmaceutical Sciences and has held a number of positions over her 35-year career in academia, including UBC Senate, Associate Dean Research & Graduate Studies and Director of Research for Angiotech Pharmaceuticals, Inc. She is also a founding scientist, and a member of the Executive and Board of Directors of the Centre for Drug Research and Development (CDRD). Burt’s research projects focus on nanotechnology as applied to the development of innovative nano-sized drug carriers. Her current major program of research is in collaboration with CDRD and CDRD Ventures Inc. and involves the development of an innovative nanoparticulate, intra-vesical drug delivery system for docetaxel for the potential treatment of superficial bladder cancer. She obtained her B. Pharm. (Hons) from the University of Bath and her Ph.D in Pharmaceutics from UBC.
Nicole Quinn
Manager, Scientific Communications and Publishing, STEMCELL Technologies
Dr. Nicole Quinn obtained her BSc and Msc in Biology from McMaster University in Hamilton, Ontario; and her PhD in Genomics from Simon Fraser University. She is currently the Scientific Communications and Publishing Manager at STEMCELL Technologies, one of the fastest growing biotech companies in Canada. She has been working at STEMCELL Technologies for the past 6 years, and in her current role for the past 4 years. Dr. Quinn’s main focus is on the Scientific Communications & Publishing program at STEMCELL. This program provides high-quality, valuable, and timely scientific content to life sciences researchers, medicals professionals and science enthusiasts, including:
– Connnexon’s 20 Science Newsletters – free weekly summaries of the latest research, news, policy, events and jobs in 20 fields of cell biology (www.connexoncreative.com)
– The Stem Cell Podcast – biweekly news summaries and interviews with global thought leaders in stem cell biology (www.stemcellpodcast.com)
– Science in the City – a website, weekly newsletter and social media network that connects Vancouver’s science community by sharing the latest local research, science news, events and jobs (www.scienceinthecity.com)
– STEMCELL’s social media channels – Facebook, LinkedIn, Twitter, ResearchGate and WeChat
– STEMCELL Public Relations – press releases, interviews, events and corporate communications for STEMCELL (https://www.stemcell.com/about-us/news.html)
2018 Exhibitors
AbCellera
CDRD
KPMG
Precision NanoSystems Inc.
STEMCELLTechnologies
Companies Represented by Mentors, Sponsors, Speakers, and Exhibitors from 2017
AbCellera
Amgen
Avigilon
BC Bioenergy Network
BDO Canada
Borden Ladner Gervais LLP
Cannevert Therapeutics Ltd
CAPRA International
Cardiome Pharma Corp
CDRD
Centre for Heart Lung Innovation, UBC
CPBC
DelMar Pharmaceuticals, Inc.
Fraser Northwest Division of Family Practice
Genentech
Kairos Therapeutics
KPMG
Malachite Management Inc.
Maxxam Analytics
Mitacs
Pacific BioVentures
Precision NanoSystems Inc.
Qu Biologics
SFU
SFU Science
Society for Canadian Women in Science and Tech (SCWIST)
STEMCELL Technologies Inc.
UBC Neuroscience
University of British Columbia
